Describe incidence rates for the most common cancers in Latin American adolescents and young adults (AYA).
Methods:
Incidence data were extracted from the Cancer Incidence in Five Continents series, available online (IARC). Age-standardized incidence rates and trend analysis were calculated. Trends were calculated by joinpoint regression analysis to obtain average annual percentage change values.
Results:
There were 22,990 invasive incident cancer cases in AYA between 1998 and 2007, obtained from 24 population-based cancer registries. The most common cancer in males was gonadal germ cell tumor, with incidence rates ranging from 1.7 to 7.0/100,000; in females the most common cancer was thyroid cancer, with rates ranging from 0.9 to 10.0/100,000. Incidence trends were limited to four regional populations and increased for all malignancies, in males from 1.8% to 3.4% and in females from 0.9% to 1.8%.
Conclusions:
Cancer incidence rates in Latin American AYA are low. There are few PBCRs with long-term data, and therefore, the results herein presented are a partial view of cancer in Latin American AYA populations.
Get full access to this article
View all access options for this article.
References
1.
FerlayJ, SoerjomataramI, DikshitR, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5):E359–86.
2.
StarkDP, VassalG. Tumors in adolescents and young adults. Basel, Switzerland: Karger Postfach; 2016.
3.
BleyerA, O'LearyM, BarrR, RiesLAG, eds. Cancer epidemiology in older adolescents and young adults 15–29 years of age, including SEER incidence and survival: 1975–2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006. Accessed October17, 2017 from: https://seer.cancer.gov/archive/publications/aya
4.
BleyerA, BarrR, Hayes-LattinB, et al.The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8(4):288–98.
5.
SaracciR, WildC. International Agency for Research on Cancer: The First 50 Years, 1965–2015: International Agency for Research on Cancer, World Health Organization; 2015.
6.
BalmantNV, ReisRS, OliveiraJFP, et al.Cancer incidence among adolescents and young adults (15 to 29 years) in Brazil. J Pediatr Hematol Oncol. 2016; 38(3):e88–96.
7.
Fonseca de JesusVH, RibeiroTN, ChinenLTD, et al.Epidemiological profile and treatment outcomes in young adults (19–29 years of age) treated for cancer in a tertiary hospital in São Paulo, Brazil. J Adolesc Young Adult Oncol. 2017; 6(2):1–8.
8.
SierraMS, FormanD. Cancer in Central and South America: methodology. Cancer Epidemiol. 2016; 44:S11–22.
9.
FormanD, BrayF, BrewsterD, et al.Cancer incidence in five continents, vol. X (electronic version). Lyon: IARC; 2013.
CuradoMP, EdwardsBK, ShinHR, et al. (Eds). Cancer incidence in five continents. Vol IX. IARC Scientific Pub. No. 160. Lyon, France: IARC Press; 2007.
12.
PiñerosM, AbriataG, MeryL, BrayF. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica. 2017; 41:e2
13.
FerlayJ, SoerjomataramI, DikshitR, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5):E359–86.
14.
JensenOM. Cancer registration: principles and methods. Lyon, France: International Agency for Research on Cancer (IARC); 1991.
15.
FerlayJ, BrayF, Steliarova-FoucherE, et al. (Eds). Cancer incidence in five continents, CI5plus: IARC Cancer Base No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer, 2014. Accessed October17, 2017 from: http://ci5.iarc.fr
16.
BirchJM, AlstonRD, KelseyAM, et al.Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer. 2002; 87:1267–74.
17.
ParkinD, WhelanS, FerlayJ, et al.Cancer incidence in five continents. International Agency for Research on Cancer, Lyon: Vol. VII. IARC Scientific publications; 1997.
18.
BarrRD, HolowatyEJ, BirchJM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006; 106(7):1425–30.
19.
PollockBH, BirchJM. Registration and classification of adolescent and young adult cancer cases. Pediatr Blood Cancer. 2008; 50(5 Suppl):1090–3.
20.
FritzA, PercyC, JackA, et al.International classification of diseases for oncology. Geneva: World Health Organization; 2000.
21.
DollR, PayneP, WatherhouseJ (Eds). Cancer incidence in five continents Geneva. Geneva: UICC International Union Against Cancer; 1966.
22.
Joinpoint Regression Program Version 4.5.0.0, Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute, [computer program]. May2017.
23.
WatkinsL. UNDP Human Development Report 2007/2008: fighting climate change: human solidarity in a divided world. New York: Palgrave Macmillan; 2007.
24.
KatanodaK, ShibataA, MatsudaT, et al.Childhood, adolescent and young adult cancer incidence in Japan in 2009–2011. Jpn. J Clin Oncol. 2017; 47(8):762–71.
25.
WardE, DesantisC, RobbinsA, et al.Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64:83–103.
26.
BallantineK, WatsonH, MacfarlaneS, et al.Small numbers, big challenges: adolescent and young adult cancer incidence and survival in New Zealand. J Adolesc Young Adult Oncol. 2017; 6(2):277–85.
27.
BullardJ, ColemanMP, RobinsonD, et al.Completeness of cancer registration: a new method for routine use. Br J Cancer. 2000; 82:1111–6.
28.
Strasser-WeipplK, Chavarri-GuerraY, Villarreal-GarzaC, et al.Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015; 16(14):1405–38.
29.
CuradoMP, De SouzaDLB. The burden of cancer in Latin America and the Carribean. An Global Health. 2014; 80:370–7.
30.
Di CesareM, KhangYH, AsariaP. The Lancet NCD Action Group Inequalities in non-communicable diseases and effective responses. Lancet. 2013; 381:585–7.
31.
CocciaPF, PappoAS, AltmanJ, et al.Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw. 2014; 12:21–32.
32.
TroeungL, Sodhi-BerryN, MartiniA, et al.Increasing incidence of colorectal cancer in adolescents and young adults aged 15–39 years in Western Australia 1982–2007: examination of colonoscopy history. Front Public Health. 2017; 5:179.
33.
MartinsHT, BalmantNV, de Paula SilvaN, et al.Who cares for adolescents and young adults with cancer in Brazil? J Pediatr. 2017. Accessed October19, 2017 from: https://doi.org/10.1016/j.jped.2017.07.008
34.
BarrRD, RiesLA, LewisDR, et al.Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors. Cancer. 2016; 122(7):1000–8.
35.
HaggarFA, PreenDB, PereiraG, et al.Cancer incidence and mortality trends in Australian adolescents and young adults, 1982–2007. BMC Cancer. 2012; 12(1):151.
36.
EngholmG, FerlayJ, ChristensenN, et al.NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 7.3 (08.07.2016): Association of the Nordic Cancer Registries. Danish Cancer Soc. 2015. Accessed October17, 2017 from: http://www.ancr.nu
37.
RapleyEA, TurnbullC, Al OlamaAA, et al.A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009; 41(7):807–10.
38.
DieckmannK-P, PichlmeierU. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004; 22(1):2–14.
39.
PetterssonA, RichiardiL, NordenskjoldA, et al.Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007; 356(18):1835–41.
40.
ChienFL, SchwartzSM, JohnsonRH. Increase in testicular germ cell tumor incidence among Hispanic adolescents and young adults in the United States. Cancer. 2014; 120(17):2728–34.
41.
DaviesL, WelchHG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006; 295:2164–7.
42.
VergaminiLB, FrazierAL, AbrantesFL, et al.Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J Pediatr. 2014; 164:1481–5.
43.
FresneauB, DourtheM-E, JouinA, et al.Specificities of carcinomas in adolescents and young adults. Bull Cancer. 2017; 104(3):267–80.
44.
BeggsAD, HodgsonSV. Genomics and breast cancer: the different levels of inherited susceptibility. Eur J Hum Genet. 2009; 17(7):855.
45.
GittlemanHR, OstromQT, RouseCD, et al.Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2015; 121(1):102–12.
46.
Van LeeuwenMT, TurnerJJ, JoskeDJ, et al.Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006. Int J Cancer. 2014; 135(9):2146–56.
47.
DockertyJD, DraperG, VincentT, et al.Case-control study of parental age, parity and socioeconomic level in relationship to childhood cancers. Int J Epidemiol. 2001; 30:1428–37.
48.
GilhamC, PetoJ, SimpsonJ, et al.Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ. 2005; 330(7503):1294.
49.
TricoliJV, BlairDG, AndersCK, et al.Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 2016; 122(7):1017–28.
50.
MoonEK, ParkHJ, OhC-M, et al.Cancer incidence and survival among adolescents and young adults in Korea. PLoS One. 2014; 9(5):e96088.
51.
VianaLDS, BalmantNV, de Paula SilvaN, et al.Incidence trends of cervical cancer in adolescents and young adults: Brazilian Population Based Data. J Adolesc Young Adult Oncol. 2018; 7(1):54–60.
52.
BruniL, DiazM, CastellsagueX, et al.Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010; 202:1789–99.
53.
BrayF, ZnaorA, CuevaP, et al.Planning and developing population-based cancer registration in low- and middle-income settings: Lyon: International Agency for Research on Cancer (IARC Technical Publications, No. 43); 2014.
54.
International Agency for Research on Cancer (IARC). Global initiative for cancer registry development (GICR). 2016. Accessed October17, 2017 from: http://gicr.iarc.fr
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
